Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.050
-0.030 (-2.78%)
At close: Aug 10, 2026, 4:00 PM EDT
1.059
+0.009 (0.88%)
After-hours: Aug 10, 2026, 7:36 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $93.97 million as of August 10, 2026. Its market cap has increased by 69.52% in one year.
Market Cap
93.97M
Enterprise Value
60.47M
1-Year Change
69.52%
Ranking
Category
Stock Price
$1.05
ChartMarket Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $93.97M, a decrease of -63.36%. That is a compound annual growth rate of -18.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 93.97M | -21.14% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polaryx Therapeutics | 100.37M |
| ImmuCell | 99.24M |
| Oncolytics Biotech | 95.82M |
| Kalaris Therapeutics | 93.74M |
| Biomea Fusion | 92.05M |
| PolyPid | 91.46M |
| Fortress Biotech | 91.35M |
| Aldeyra Therapeutics | 91.08M |